Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 953 of 5804
-
Can cannabis compounds boost opioid addiction treatment?
Disease control Not yet recruitingThe goal of this pilot study is to test novel, adjunctive pharmacotherapy for patients with opioid use disorder (POUD) who may be at risk for overdose and other poor opioid use disorder (OUD) outcomes even after initiating buprenorphine. The investigator team proposes to test the…
Phase: PHASE3 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can green tea and quercetin boost chemo for advanced prostate cancer?
Disease control Recruiting nowThe goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer, i.e., metastatic castration-resistant prostate cancer (mCRPC). It will also learn about the safety…
Phase: PHASE1, PHASE2 • Sponsor: Charles Drew University of Medicine and Science • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New antibody drug aims to tame Hard-to-Treat kidney disease
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetics(PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of YK012 in participants with primary membranous nephropathy (pMN).
Phase: PHASE1 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Experimental drug aims to boost energy in rare genetic disorders
Disease control Not yet recruitingThis is a parallel arm non-randomized dose-escalation, open-label basket exploratory phase 1 clinical trial where Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes (MELAS) and Leber's hereditary optic neuropathy-Plus (LHON-Plus) participants will undergo simulta…
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
AI steps in to stop pain before it becomes chronic after surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a pain-management program called a Transitional Pain Service can help prevent long-term pain and reduce opioid needs after surgery in adult surgical patients who may be at higher risk for developing persistent pain. The main que…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New asthma inhaler faces off against standard treatment in major trial
Disease control Not yet recruitingThis is a Phase 3, multicenter, randomized, parallel-group, open-label, non-inferiority clinical trial designed to evaluate the efficacy and safety of N0783 compared to Alenia® (Formoterol 6 mcg / Budesonide 200 mcg) in the treatment of moderate asthma. Adult patients diagnosed w…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New scan could reveal hidden immune cells in blood vessel disease
Knowledge-focused Not yet recruitingB cells are a component of the immune system which appear be important in causing all forms of cardiovascular disease. Until now, it has not been possible to directly study these cells in living patients (essential to assess their potential as the target of new treatments). For t…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
VR game aims to keep teens off vapes
Prevention Not yet recruitingThis study will examine E-Invite Only VR, a novel school-based universal e-cigarette prevention intervention that uses virtual reality (VR) to deliver prevention and emotion regulation skills-building content to middle school students in real-world classrooms. If successful, E-in…
Phase: NA • Sponsor: Yale University • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
New vaccine aims to halt ovarian cancer recurrence detected in blood
Disease control Not yet recruitingThis phase II trial studies how well giving the insulin-like growth factor binding protein 2 \[pUMVC3-hIGFBP-2 multi-epitope plasmid deoxyribonucleic acid (DNA) (IGFBP-2)\] vaccine after one dose of carboplatin works to stop ovarian cancer from growing, spreading, or getting wors…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug UX016 targets rare muscle disease
Disease control Not yet recruitingThe main goal of this study is to evaluate the safety of UX016 and to evaluate the impact of UX016 on muscle strength in adults with GNE Myopathy (GNEM).
Phase: PHASE1, PHASE2 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New shot aims to clear stubborn HPV infection in women
Disease control Not yet recruitingThis is a two-part, phase I/IIa study, intended to evaluate the safety, tolerability, immunogenicity, and efficacy of NWRD09 in female participants with persistent HPV16 infection, and to determine the MTD, and/or RP2D of NWRD09.
Phase: PHASE1, PHASE2 • Sponsor: Newish Biotech (Wuxi) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Can a remote nurse boost HIV prevention at kenyan pharmacies?
Prevention Not yet recruitingIn this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continu…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
New drug targets pancreatic cancer before surgery
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and efficacy of samuraciclib in patients with localized pancreatic cancer.
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a common acne drug help beat tough fungal infections?
Disease control Not yet recruitingTinea corporis and tinea cruris are common superficial fungal infections that have become increasingly difficult to treat because of prolonged disease duration, frequent recurrences, and suboptimal response to standard antifungal therapy. Itraconazole is widely used for the treat…
Phase: PHASE4 • Sponsor: Pak Emirates Military Hospital • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Growing healthy hearts: family gardening may reduce cardiovascular risk
Disease control Not yet recruitingThis proposal includes a prospective, parallel group, two-arm RCT with 264 adult-child dyads (adult age 18+, child ages 5-17 years) to examine the effectiveness of the Growing Healthy Hearts (GHH) intervention versus a wait list control on cardiovascular and behavioral health out…
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New coil system aims to safely block dangerous brain vessels
Disease control Not yet recruitingThis is a prospective, multicenter, post-market clinical follow-up (PMCF) study to collect safety and performance data in patients with arteriovenous malformations (AVMs) who undergo endovascular coil embolization using the i-ED Coil and Electro Detach Generator v4 (EDG v4).
Phase: NA • Sponsor: Kaneka Corporation • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Pre-surgery energy flexibility may flag heart risk after cancer surgery
Knowledge-focused Not yet recruitingThe goal of this observational study is to learn whether metabolic inflexibility, which means reduced ability of the body to switch between using fats and sugars for energy, is associated with myocardial injury after non-cardiac surgery (MINS) in adults undergoing major elective …
Sponsor: University College, London • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
Gut and mouth bacteria may predict who benefits from probiotics for gum disease
Disease control Not yet recruitingProbiotics are live microorganisms that can be taken as supplements and have shown promise in playing a beneficial role in improving clinical conditions that are characterized by chronic inflammation, such as periodontal disease (PD). The human gut microbiome is composed of trill…
Phase: NA • Sponsor: University of New Hampshire • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a blood clot or platelet fibrin help save a tooth that failed root canal?
Disease control Not yet recruitingThis clinical study aims to compare the clinical and radiographic outcomes of four different scaffolds used in regenerative endodontic treatment of previously root canal-treated permanent teeth requiring retreatment. Participants will be randomly assigned to one of four groups b…
Sponsor: Kırıkkale University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can an old alcohol-dependence drug help the immune system fight brain cancer?
Disease control Not yet recruitingThis research study is for participants with glioblastoma. It can cause a tumor immunosuppression which helps myeloid cells that can stop T-cell function. Disulfiram is a drug that has been used in treating other disorders, but this study will examine if disulfiram can help make …
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC